epiSCI is undertaking a systematic analysis of cancer stem cell markers, accumulating a knowledge database for over 200 cancer indications and the associated normal epithelial stem cells identifying druggable carcinogenic pathways that distinguish cancer stem cells from normal stem cells.

Our goal is to develop novel commercial applications of stem cell biomarkers for therapeutics, diagnostics and targeted drug delivery.